交易季度统计报告

2025-09资本市场13免费

📄 文件全名: 《交易季度统计报告-13页.pdf》
🎯 适合读者: 投资人行业研究员
📊 核心数据: category made up the greatest proportion of both the aggregate Q2 financing dollars (26%) and deal volume (33%)
There were 67 biopharmas together raising $4.6bn through 47 early-stage rounds totaling $2.9bn (16% of the
quarter’s dollars) and 20 late-stage rounds totaling $1.7bn (10% of the Q2 dollars). Early-stage rounds had an
Debt offerings represented the second-highest share of deal dollars (21%), with 18 deals bringing in an aggregate
🏷️ 核心议题: #IPO

📦 本报告属于月份合集

购买后将获得「2025 年 9 月报告合集」 · 共 4294 份报告打包下载链接

点击获取云盘下载链接

报告摘要

❓ 常见问题

《交易季度统计报告》主要包含哪些内容?

Financing Quarterly During Q2, biopharmas brought in an aggregate $17.5bn in financing and device company fundraising totaled $2.7bn; while in vitro diagnostic firms and research tools players raised $1.7bn.核心数据:category made up the greatest proportion of both the aggregate Q2 financing dollars (26%) and deal volume (33%);There were 67 biopharmas together raising $4.6bn through 47 early-stage rounds totaling $2.9bn (16% of the;quarter’s dollars) and 20 late-stage rounds totaling $1.7bn (10% of the Q2 dollars). Early-stage rounds had an。

这份报告覆盖哪一年、篇幅多大?

覆盖 2025 年,全文约 13。

这份报告是免费的吗?如何获取?

本报告免费查阅,登录资料宝后即可在线获取完整内容。

这份报告适合哪些读者?

适合投资人、行业研究员等读者参考。

报告涉及哪些关键议题?

重点分析了IPO等议题。